Cargando…
SAT-003 Therapeutic Glucocorticoids Prevent Local and Systemic Bone Loss but Exacerbate Muscle Wasting When Administered in Chronic Inflammation
Glucocorticoids (GCs) are used in the treatment of chronic inflammatory diseases due to their potent anti-inflammatory actions. Their use is limited due to major systemic side effects including osteoporosis and muscle wasting. This is further complicated by pre-existing inflammatory muscle wasting a...
Autores principales: | Fenton, Chloe, Webster, Justine, Fareed, Syeda, Martin, Claire, Wehmeyer, Corinna, Cooper, Mark, Buckley, Chris, Lavery, Gareth, Langen, Ramon, Raza, Karim, Hardy, Rowan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Endocrine Society
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6552069/ http://dx.doi.org/10.1210/js.2019-SAT-003 |
Ejemplares similares
-
OR09-3 11β-HSD1 Mediates a Partial Suppression of Muscle Atrophy in Chronic Inflammatory Disease in Response to Therapeutic Glucocorticoids
por: Webster, Justine, et al.
Publicado: (2019) -
SAT-LB003 Nonsmokers Benefit from Lower Doses of an Estradiol/Progesterone Combination: Results of the REPLENISH Trial
por: Constantine, Ginger, et al.
Publicado: (2019) -
SAT-020 Empiric Determination of Daily Glucocorticoid Replacement Doses in Adrenal Insufficiency
por: Caetano, Celina, et al.
Publicado: (2019) -
SAT-740 Plasma Glucocorticoids and Mineralocorticoids Are Associated to Metabolic Syndrome Features in Women
por: Ostinelli, Giada, et al.
Publicado: (2020) -
SAT-008 Overcoming BCL-2 Resistance in Glucocorticoid-Treated Tumor Lymphoid Cells
por: Bortner, Carl, et al.
Publicado: (2019)